Chou, Cassie K.
Turtle, Cameron J.
Article History
First Online: 20 August 2019
Compliance with ethical standards
:
: CKC declared no competing interests. CJT received consulting fees from Juno Therapeutics, Celgene, Nektar Therapeutics, Precision Biosciences, Eureka Therapeutics, Caribou Biosciences, Gilead, Bluebird, Adaptive Biotechnologies, Aptevo, research funding from Juno Therapeutics, Celgene, Nektar Therapeutics and holds patents licensed to cover technology related to cellular therapies with Juno/Celgene.